Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
2026 report covers MemoryON ingredient dosages, Bacopa and Phosphatidylserine research context, St. John's Wort safety, and pricing details.
-
Aleanna 2025 Q4 and Full Year Results
-
Brain Savior explains its Brain Honey formula claims, Citicoline and Bacopa Monnieri research, and cognitive support positioning for 2026.
-
CHICO, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- Lulu’s Fashion Lounge Holdings, Inc. (“Lulus” or the “Company”) (Nasdaq: LVLU) today reported financial results for the fourth quarter and fiscal...
-
Carpinteria, CA, March 30, 2026 (GLOBE NEWSWIRE) -- This announcement is based on publicly available materials from ProHealth Longevity regarding its BPC-157 formulation, including how the product...
-
2025 Total Revenue of $241.6 million (approximately $315.0 million including Bayswater), an increase of approximately 3,000% year-over-yearRecord Adjusted EBITDA(1) of $155.5 million (approximately...
-
AquaBurn 2026 brown fat thermogenic formula: ingredient research context, product disclosures, and supplement vs. prescription distinctions.
-
ARLINGTON, VA, March 30, 2026 (GLOBE NEWSWIRE) -- The Aluminum Association continues to monitor the ongoing situation in the Gulf region and the implications for the domestic aluminum industry. On...
-
Financial Press Release : Annual results 2025 Reims, March 30, 2026 The Board of Directors of Maison Pommery & Associés met on March 30, 2026, under the chairmanship of Mr. Paul François...
-
– Analysis Demonstrated 22% Reduced Risk of Ischemic Stroke for Patients Taking Bempedoic Acid Compared to Placebo – – Analysis of CLEAR Outcomes Reports Bempedoic Acid Reduced MACE in High-Risk...